<?xml version="1.0" encoding="UTF-8"?>
<p id="Par4">The hypothesis underlying precision medicine is that diseases previously treated as a single condition are actually biologically different, and that treatment should be tailored based on the biological signature of the individual (stratified medicine [
 <xref ref-type="bibr" rid="CR3">3</xref>]). A successful example is oncology, where precision medicine led to the identification of effective therapies based on tumor profiling and a better understanding of how tumors become resistant to cancer therapyÂ (
 <ext-link ext-link-type="uri" xlink:href="https://www.cancer.gov/research/areas/treatment/pmi-oncology" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.cancer.gov/research/areas/treatment/pmi-oncology</ext-link>). In PD, precision trials are ongoing for genetic forms of PD.
</p>
